Select therapeutic use:
Indications for PROLASTIN-C:
For chronic augmentation and maintenance therapy in adults with clinical evidence of emphysema due to severe alpha1-proteinase inhibitor deficiency.
Give by IV infusion at a rate of 0.08mL/kg/min. 60mg/kg once weekly.
IgA deficient patients with antibodies against IgA.
Contains human plasma; monitor for possible infection transmission (eg, viruses, Creutzfeldt-Jakob disease agent). Pregnancy (Cat.C). Nursing mothers.
Upper respiratory tract infection, UTI, nausea, pain, chills, cough, dizziness, dyspnea, headache, hot flush, oral candidiasis; rash, hypersensitivity reactions (discontinue if occur).
Single-use vial—1 (w. diluent + needles)